BioCentury
ARTICLE | Financial News

Molecular Insight financial update

October 18, 2010 7:00 AM UTC

Molecular Insight received letters from NASDAQ indicating the company is not in compliance with the $1 minimum bid price or $15 million in market capitalization requirements for continued listing. The...